IL6 and Friedreich ataxia: The augmented binding of [18 F]-FEMPA was correlated with earlier disease onset, shorter disease duration, and an increase in plasma inflammatory cytokines, among which was interleukin-6 (IL-6) in patients with FRDA, indicating that chronic neuroinflammation could be a critical pathogenic mechanism in the disease [34].